Cancer chemotherapy-induced nausea and vomiting

Cancer chemotherapy-induced nausea and vomiting is an adverse clinical condition characterized by subjective stomach discomfort and the forceful expulsion of gastric contents triggered by antineoplastic drug administration

Cancer chemotherapy-induced nausea and vomiting is an adverse clinical condition characterized by subjective stomach discomfort and the forceful expulsion of gastric contents triggered by antineoplastic drug administration Primarily involving the gastrointestinal tract and the central nervous system, it occurs when cytotoxic agents damage enterochromaffin cells in the gut and stimulate the chemoreceptor trigger zone, releasing key neurochemical mediators such as serotonin and substance P. Clinic...

Primarily involving the gastrointestinal tract and the central nervous system, it occurs when cytotoxic agents damage enterochromaffin cells in the gut and stimulate the chemoreceptor trigger zone, releasing key neurochemical mediators such as serotonin and substance P

Primarily involving the gastrointestinal tract and the central nervous system, it occurs when cytotoxic agents damage enterochromaffin cells in the gut and stimulate the chemoreceptor trigger zone, releasing key neurochemical mediators such as serotonin and substance P

Primarily involving the gastrointestinal tract and the central nervous system, it occurs when cytotoxic agents damage enterochromaffin cells in the gut and stimulate the chemoreceptor trigger zone, releasing key neurochemical mediators such as serotonin and substance P. Clinically, it manifests across acute, delayed, or anticipatory phases depending on drug emetogenicity and timing, frequently predisposing oncology patients to complications like dehydration, malnutrition, and reduced treatment a...

Primarily involving the gastrointestinal tract and the central nervous system, it occurs when cytotoxic agents damage enterochromaffin cells in the gut and stimulate the chemoreceptor trigger zone, releasing key neurochemical mediators such as serotonin and substance P. Clinically, it manifests across acute, delayed, or anticipatory phases depending on drug emetogenicity and timing, frequently predisposing oncology patients to complications like dehydration, malnutrition, and reduced treatment a...